Curriculum Vitae

Scopus ID: 8886437100

Dr Mussolin graduated in Biology with 110/110 at the School of Biological Sciences, University of Padua in 1999. Research Doctorate in Oncological Sciences of Childhood, University of Padua, in 2004. Specialization in Clinical Pathology with 70/70 with honors at the School of Medicine, University of Padua. Since 2001 head of molecular diagnostic of non-Hodgkin lymphomas (NHL) of childhood unit in the laboratory, that centralizes samples from all Italian AIEOP (Associazione Italiana di Emato-OncologiaPediatrica) clinical centres. Member of the EICNHL (European InterGroup of Non-Hodgkin Lym-phoma) Group for the study of Minimal Residual Disease in non-Hodgkin Lymphoma of childhood. Member of the of non-Hodgkin Lymphoma working Group, member of the Biology working Group and member of the Hodgkin lymphoma working Group of AIEOP Association. Involved in laboratory research aimed at identifying new prognostic markers in NHL through modern molecular techniques (i.e. microarray, RNAseq). Invited to numerous national and international conferences as a speaker. Teaching activities in the University Master’s Degree in Pediatric Hematology organized biannual by the Faculty of Medicine of the University of the Studies of Rome La Sapienza. Author of over 50 publications on international journals and of over 100 abstracts selected for poster or oral presentations at international and national scientific meetings. ISI WOS H-index >20; number of citations> 1000. Awards: Travel award for young investigators sponsored by“Swiss Lega against Cancer“(2008); Travel award for young investigators sponsored by the American Society of Hematology (2009);“Guido Berlucchi” award for young investigators sponsored by “Fondazione Guido Berlucchi” for cancer research (2010); “Mario Moroni” award sponsored by Gilead Sciences (2019).


Latest pubblications: Click here

Related Laboratories

Molecular Diagnostic of Non Hodgkin Lymphoma

Our research area is dedicated mainly to the study and characterization of Non-Hodgkin lymphoma (NLH) of childhood. The general approach includes the analysis of molecular mechanisms of tumourigenesis with a translational approach aimed to transfer biological results from the bench to clinical trials...